Professor Peter Mills
- Honorary Senior Research Fellow (School of Medicine, Dentistry & Nursing)
Publications
2019
Lee, K. K. et al. (2019) Global burden of atherosclerotic cardiovascular disease in people living with the hepatitis C virus: a systematic review, meta-analysis and modelling study. Lancet Gastroenterology and Hepatology, 4(10), pp. 794-804. (doi: 10.1016/S2468-1253(19)30227-4) (PMID:31377134) (PMCID:PMC6734111)
2017
Innes, H. et al. (2017) Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population. Journal of Hepatology, 66(1), pp. 19-27. (doi: 10.1016/j.jhep.2016.08.004) (PMID:27545496)
2016
Mandalou, P., Spence, E., Datta, S. and Mills, P.R. (2016) Raised serum transaminases during treatment with pegylated interferon for chronic hepatiti C. Clinical Microbiology and Infectious Diseases, 1(3), pp. 73-77. (doi: 10.15761/CMID.1000116)
Weir, A. et al. (2016) Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs. Drug and Alcohol Dependence, 165, pp. 53-60. (doi: 10.1016/j.drugalcdep.2016.05.012) (PMID:27268294)
Bulteel, N. et al. (2016) Factors associated with spontaneous clearance of chronic hepatitis C virus infection. Journal of Hepatology, 65(2), pp. 266-272. (doi: 10.1016/j.jhep.2016.04.030) (PMID:27155531)
Robinson, M. W., Hughes, J. , Wilkie, G. S., Swann, R. , Barclay, S. T., Mills, P. R., Patel, A. H. , Thomson, E. C. and McLauchlan, J. (2016) Tracking TCRß sequence clonotype expansions during antiviral therapy using high-throughput sequencing of the hypervariable region. Frontiers in Immunology, 7, 131. (doi: 10.3389/fimmu.2016.00131) (PMID:27092143) (PMCID:PMC4820669)
Clarke, A. T., Johnson, P. C.D. , Hall, G. C., Ford, I. and Mills, P. (2016) High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort. PLoS ONE, 11(3), e0151587. (doi: 10.1371/journal.pone.0151587) (PMID:26983033) (PMCID:PMC4794178)
2015
Robinson, M. W. et al. (2015) Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection. Liver International, 35(10), pp. 2256-2264. (doi: 10.1111/liv.12830) (PMID:25800823) (PMCID:PMC4949513)
Innes, H.A. et al. (2015) Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology, 62(2), pp. 355-364. (doi: 10.1002/hep.27766) (PMID:25716707)
2014
Stanley, A. J. et al. (2014) Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. Journal of Hepatology, 61(5), pp. 1014-1019. (doi: 10.1016/j.jhep.2014.06.015) (PMID:24953021)
Mustafa, M. Z. et al. (2014) The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia. Journal of Viral Hepatitis, 21(7), e48-e51. (doi: 10.1111/jvh.12234) (PMID:24533990)
Innes, H., Goldberg, D., Dusheiko, G., Hayes, P., Mills, P. R., Dillon, J. F., Aspinall, E., Barclay, S. T. and Hutchinson, S. J. (2014) Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model. Journal of Hepatology, 60(6), pp. 1118-1126. (doi: 10.1016/j.jhep.2014.01.020)
2013
Robinson, M. W., McGuinness, D., Swann, R. , Barclay, S., Mills, P. R., Patel, A. H. , McLauchlan, J. and Shiels, P. G. (2013) Non cell autonomous upregulation of CDKN2 transcription linked to progression of chronic hepatitis C disease. Aging Cell, 12(6), pp. 1141-1143. (doi: 10.1111/acel.12125) (PMID:23931242)
McDonald, S.A. et al. (2013) Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's hepatitis C action plan. Journal of Viral Hepatitis, 21(5), pp. 366-376. (doi: 10.1111/jvh.12153) (PMID:24716639)
Tedder, R.S. et al. (2013) The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call. Clinical Infectious Diseases, 56(7), pp. 951-960. (doi: 10.1093/cid/cis1013)
Innes, H.A. et al. (2013) Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology, 57(2), pp. 451-460. (doi: 10.1002/hep.26051)
2012
Innes, H. et al. (2012) Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland. European Journal of Gastroenterology and Hepatology, 24(6), pp. 646-655. (doi: 10.1097/MEG.0b013e32835201a4) (PMID:22433796)
Tanwar, S., Wright, M., Foster, G.R., Ryder, S.D., Mills, P.R., Cramp, M.E., Parkes, J. and Rosenberg, W.M. (2012) Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon alpha-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis. European Journal of Gastroenterology and Hepatology, 24(5), pp. 543-550. (doi: 10.1097/MEG.0b013e3283513e69)
2011
McDonald, S.A., Hutchinson, S.J., Bird, S.M., Robertson, C., Mills, P.R., Dillon, J.F. and Goldberg, D.J. (2011) Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection. International Journal of Drug Policy, 22(1), pp. 63-69. (doi: 10.1016/j.drugpo.2010.04.003)
2010
Barclay, S.T. et al. (2010) The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993-2007. Scottish Medical Journal, 55(3), pp. 4-7. (doi: 10.1258/rsmsmj.55.3.4) (PMID:20795508)
McDonald, S. A., Hutchinson, S.J., Mills, P.R., Bird, S. M., Cameron, S., Dillon, J.F. and Goldberg, D.J. (2010) The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow’s injecting drug user population. Journal of Viral Hepatitis, 18(4), e126-e133. (doi: 10.1111/j.1365-2893.2010.01380.x)
McDonald, S.A., Hutchinson, S.J., Cameron, S., Bird, S.M., Mills, P.R., McLeod, A. and Goldberg, D.J. (2010) Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007. Journal of Viral Hepatitis, 18(4), e61-e65. (doi: 10.1111/j.1365-2893.2010.01377.x)
2009
Tripathi, D. et al. (2009) Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology, 50(3), pp. 825-833. (doi: 10.1002/hep.23045) (PMID:19610055)
2008
Watkins, S., Thorburn, D., Joshi, N., Neilson, M., Joyce, T., Spooner, R., Cooke, A., Mills, P. R., Morris, A. J. and Stanley, A. J. (2008) The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. European Journal of Gastroenterology and Hepatology, 20(5), pp. 379-383. (doi: 10.1097/MEG.0b013e3282f3e708) (PMID:18403938)
2003
Thorburn, D., Morris, A.J., Stanley, A.J. and Mills, P.R. (2003) Underdiagnosis of hereditary haemochromatosis: reflects lack of clinical not biochemical penetrance. Gut, 52(3), p. 455. (doi: 10.1136/gut.52.3.455) (PMID:12584238) (PMCID:PMC1773541)
Shaw, M.L., McLauchlan, J. , Mills, P.R., Patel, A.H. and McCruden, E.A.B. (2003) Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins. Journal of Medical Virology, 70(3), pp. 361-372. (doi: 10.1002/jmv.10404)
2002
Lui, H. F., Stanley, A. J. , Forrest, E. H., Rajiv, J., Hislop, W. S., Mills, P. R., Finlayson, N. D.C., MacGilchrist, A. and Hayes, P. C. (2002) Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology, 123(3), pp. 735-744. (doi: 10.1053/gast.2002.35385) (PMID:12198700)
2001
Henderson, L., Muir, M., Mills, P.R., Spence, E., Fox, R., McCruden, E.A.B. and Bagg, J. (2001) Oral health of patients with hepatitis C virus infection: a pilot study. Oral Diseases, 7(5), 271 -275. (doi: 10.1034/j.1601-0825.2001.00695.x)
1999
Oien, K. A. , Moffat, D., Curry, G. W., Dickson, J., Habeshaw, T., Mills, P. R. and MacSween, R. N. (1999) Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet, 353(9146), pp. 36-37. (doi: 10.1016/S0140-6736(05)74872-8)
Articles
Lee, K. K. et al. (2019) Global burden of atherosclerotic cardiovascular disease in people living with the hepatitis C virus: a systematic review, meta-analysis and modelling study. Lancet Gastroenterology and Hepatology, 4(10), pp. 794-804. (doi: 10.1016/S2468-1253(19)30227-4) (PMID:31377134) (PMCID:PMC6734111)
Innes, H. et al. (2017) Mortality in hepatitis C patients who achieve a sustained viral response compared to the general population. Journal of Hepatology, 66(1), pp. 19-27. (doi: 10.1016/j.jhep.2016.08.004) (PMID:27545496)
Mandalou, P., Spence, E., Datta, S. and Mills, P.R. (2016) Raised serum transaminases during treatment with pegylated interferon for chronic hepatiti C. Clinical Microbiology and Infectious Diseases, 1(3), pp. 73-77. (doi: 10.15761/CMID.1000116)
Weir, A. et al. (2016) Hepatitis C reinfection following treatment induced viral clearance among people who have injected drugs. Drug and Alcohol Dependence, 165, pp. 53-60. (doi: 10.1016/j.drugalcdep.2016.05.012) (PMID:27268294)
Bulteel, N. et al. (2016) Factors associated with spontaneous clearance of chronic hepatitis C virus infection. Journal of Hepatology, 65(2), pp. 266-272. (doi: 10.1016/j.jhep.2016.04.030) (PMID:27155531)
Robinson, M. W., Hughes, J. , Wilkie, G. S., Swann, R. , Barclay, S. T., Mills, P. R., Patel, A. H. , Thomson, E. C. and McLauchlan, J. (2016) Tracking TCRß sequence clonotype expansions during antiviral therapy using high-throughput sequencing of the hypervariable region. Frontiers in Immunology, 7, 131. (doi: 10.3389/fimmu.2016.00131) (PMID:27092143) (PMCID:PMC4820669)
Clarke, A. T., Johnson, P. C.D. , Hall, G. C., Ford, I. and Mills, P. (2016) High dose atorvastatin associated with increased risk of significant hepatotoxicity in comparison to simvastatin in UK GPRD cohort. PLoS ONE, 11(3), e0151587. (doi: 10.1371/journal.pone.0151587) (PMID:26983033) (PMCID:PMC4794178)
Robinson, M. W. et al. (2015) Viral genotype correlates with distinct liver gene transcription signatures in chronic hepatitis C virus infection. Liver International, 35(10), pp. 2256-2264. (doi: 10.1111/liv.12830) (PMID:25800823) (PMCID:PMC4949513)
Innes, H.A. et al. (2015) Toward a more complete understanding of the association between a hepatitis C sustained viral response and cause-specific outcomes. Hepatology, 62(2), pp. 355-364. (doi: 10.1002/hep.27766) (PMID:25716707)
Stanley, A. J. et al. (2014) Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding. Journal of Hepatology, 61(5), pp. 1014-1019. (doi: 10.1016/j.jhep.2014.06.015) (PMID:24953021)
Mustafa, M. Z. et al. (2014) The efficacy and safety of treating hepatitis C in patients with a diagnosis of schizophrenia. Journal of Viral Hepatitis, 21(7), e48-e51. (doi: 10.1111/jvh.12234) (PMID:24533990)
Innes, H., Goldberg, D., Dusheiko, G., Hayes, P., Mills, P. R., Dillon, J. F., Aspinall, E., Barclay, S. T. and Hutchinson, S. J. (2014) Patient-important benefits of clearing the hepatitis C virus through treatment: a simulation model. Journal of Hepatology, 60(6), pp. 1118-1126. (doi: 10.1016/j.jhep.2014.01.020)
Robinson, M. W., McGuinness, D., Swann, R. , Barclay, S., Mills, P. R., Patel, A. H. , McLauchlan, J. and Shiels, P. G. (2013) Non cell autonomous upregulation of CDKN2 transcription linked to progression of chronic hepatitis C disease. Aging Cell, 12(6), pp. 1141-1143. (doi: 10.1111/acel.12125) (PMID:23931242)
McDonald, S.A. et al. (2013) Attendance at specialist hepatitis clinics and initiation of antiviral treatment among persons chronically infected with hepatitis C: examining the early impact of Scotland's hepatitis C action plan. Journal of Viral Hepatitis, 21(5), pp. 366-376. (doi: 10.1111/jvh.12153) (PMID:24716639)
Tedder, R.S. et al. (2013) The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call. Clinical Infectious Diseases, 56(7), pp. 951-960. (doi: 10.1093/cid/cis1013)
Innes, H.A. et al. (2013) Quantifying the fraction of cirrhosis attributable to alcohol among chronic hepatitis C virus patients: implications for treatment cost-effectiveness. Hepatology, 57(2), pp. 451-460. (doi: 10.1002/hep.26051)
Innes, H. et al. (2012) Ranking predictors of a sustained viral response for patients with chronic hepatitis C treated with pegylated interferon and ribavirin in Scotland. European Journal of Gastroenterology and Hepatology, 24(6), pp. 646-655. (doi: 10.1097/MEG.0b013e32835201a4) (PMID:22433796)
Tanwar, S., Wright, M., Foster, G.R., Ryder, S.D., Mills, P.R., Cramp, M.E., Parkes, J. and Rosenberg, W.M. (2012) Randomized clinical trial: a pilot study investigating the safety and effectiveness of an escalating dose of peginterferon alpha-2a monotherapy for 48 weeks compared with standard clinical care in patients with hepatitis C cirrhosis. European Journal of Gastroenterology and Hepatology, 24(5), pp. 543-550. (doi: 10.1097/MEG.0b013e3283513e69)
McDonald, S.A., Hutchinson, S.J., Bird, S.M., Robertson, C., Mills, P.R., Dillon, J.F. and Goldberg, D.J. (2011) Hospitalisation for an alcohol-related cause among injecting drug users in Scotland: Increased risk following diagnosis with hepatitis C infection. International Journal of Drug Policy, 22(1), pp. 63-69. (doi: 10.1016/j.drugpo.2010.04.003)
Barclay, S.T. et al. (2010) The changing face of hepatitis B in greater Glasgow: epidemiological trends 1993-2007. Scottish Medical Journal, 55(3), pp. 4-7. (doi: 10.1258/rsmsmj.55.3.4) (PMID:20795508)
McDonald, S. A., Hutchinson, S.J., Mills, P.R., Bird, S. M., Cameron, S., Dillon, J.F. and Goldberg, D.J. (2010) The influence of hepatitis C and alcohol on liver-related morbidity and mortality in Glasgow’s injecting drug user population. Journal of Viral Hepatitis, 18(4), e126-e133. (doi: 10.1111/j.1365-2893.2010.01380.x)
McDonald, S.A., Hutchinson, S.J., Cameron, S., Bird, S.M., Mills, P.R., McLeod, A. and Goldberg, D.J. (2010) Uptake of hepatitis C antibody testing in patients with end-stage liver disease in Glasgow, 1993-2007. Journal of Viral Hepatitis, 18(4), e61-e65. (doi: 10.1111/j.1365-2893.2010.01377.x)
Tripathi, D. et al. (2009) Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed. Hepatology, 50(3), pp. 825-833. (doi: 10.1002/hep.23045) (PMID:19610055)
Watkins, S., Thorburn, D., Joshi, N., Neilson, M., Joyce, T., Spooner, R., Cooke, A., Mills, P. R., Morris, A. J. and Stanley, A. J. (2008) The biochemical and clinical penetrance of individuals diagnosed with genetic haemochromatosis by predictive genetic testing. European Journal of Gastroenterology and Hepatology, 20(5), pp. 379-383. (doi: 10.1097/MEG.0b013e3282f3e708) (PMID:18403938)
Thorburn, D., Morris, A.J., Stanley, A.J. and Mills, P.R. (2003) Underdiagnosis of hereditary haemochromatosis: reflects lack of clinical not biochemical penetrance. Gut, 52(3), p. 455. (doi: 10.1136/gut.52.3.455) (PMID:12584238) (PMCID:PMC1773541)
Shaw, M.L., McLauchlan, J. , Mills, P.R., Patel, A.H. and McCruden, E.A.B. (2003) Characterisation of the differences between hepatitis C virus genotype 3 and 1 glycoproteins. Journal of Medical Virology, 70(3), pp. 361-372. (doi: 10.1002/jmv.10404)
Lui, H. F., Stanley, A. J. , Forrest, E. H., Rajiv, J., Hislop, W. S., Mills, P. R., Finlayson, N. D.C., MacGilchrist, A. and Hayes, P. C. (2002) Primary prophylaxis of variceal hemorrhage: a randomized controlled trial comparing band ligation, propranolol, and isosorbide mononitrate. Gastroenterology, 123(3), pp. 735-744. (doi: 10.1053/gast.2002.35385) (PMID:12198700)
Henderson, L., Muir, M., Mills, P.R., Spence, E., Fox, R., McCruden, E.A.B. and Bagg, J. (2001) Oral health of patients with hepatitis C virus infection: a pilot study. Oral Diseases, 7(5), 271 -275. (doi: 10.1034/j.1601-0825.2001.00695.x)
Oien, K. A. , Moffat, D., Curry, G. W., Dickson, J., Habeshaw, T., Mills, P. R. and MacSween, R. N. (1999) Cirrhosis with steatohepatitis after adjuvant tamoxifen. Lancet, 353(9146), pp. 36-37. (doi: 10.1016/S0140-6736(05)74872-8)